Warning! GuruFocus detected
1 Severe warning sign
with SLDB.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Solid Biosciences Inc
NAICS : 325411
SIC : 2836
ISIN : US83422E1055
Compare
Compare
Traded in other countries / regions
SLDB.USA Index Membership
Russell 2000Russell 3000Russell 2000 IPO Date
2018-01-25Description
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.16 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 32.6 | |||||
| 3-Year EPS without NRI Growth Rate | 33.8 | |||||
| 3-Year FCF Growth Rate | 39.4 | |||||
| 3-Year Book Growth Rate | -50.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 6.97 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.4 | |||||
| 9-Day RSI | 47.66 | |||||
| 14-Day RSI | 51.62 | |||||
| 3-1 Month Momentum % | -17.92 | |||||
| 6-1 Month Momentum % | -49.18 | |||||
| 12-1 Month Momentum % | -67.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | |||||
| Quick Ratio | 5.2 | |||||
| Cash Ratio | 4.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -76.5 | |||||
| Shareholder Yield % | -30.07 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -74.69 | |||||
| ROA % | -59.66 | |||||
| ROIC % | -309.31 | |||||
| 3-Year ROIIC % | -270 | |||||
| ROC (Joel Greenblatt) % | -399.69 | |||||
| ROCE % | -65.56 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.5 | |||||
| Price-to-Tangible-Book | 1.5 | |||||
| EV-to-EBIT | -2.2 | |||||
| EV-to-EBITDA | -2.25 | |||||
| EV-to-FCF | -2.72 | |||||
| Price-to-Net-Current-Asset-Value | 1.94 | |||||
| Price-to-Net-Cash | 2.11 | |||||
| Earnings Yield (Greenblatt) % | -45.45 | |||||
| FCF Yield % | -25.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SLDB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Solid Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.06 | ||
| Beta | 2.58 | ||
| 3-Year Sharpe Ratio | 0.25 | ||
| 3-Year Sortino Ratio | 0.49 | ||
| Volatility % | 128.54 | ||
| 14-Day RSI | 51.62 | ||
| 14-Day ATR ($) | 0.557394 | ||
| 20-Day SMA ($) | 5.42175 | ||
| 12-1 Month Momentum % | -67.18 | ||
| 52-Week Range ($) | 2.88 - 15.05 | ||
| Shares Outstanding (Mil) | 77.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Solid Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Solid Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Solid Biosciences Inc Frequently Asked Questions
What is Solid Biosciences Inc(SLDB)'s stock price today?
The current price of SLDB is $5.09. The 52 week high of SLDB is $15.05 and 52 week low is $2.88.
When is next earnings date of Solid Biosciences Inc(SLDB)?
The next earnings date of Solid Biosciences Inc(SLDB) is 2025-05-15 Est..
Does Solid Biosciences Inc(SLDB) pay dividends? If so, how much?
Solid Biosciences Inc(SLDB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers